Loading…

Hodgkin’s cells express CD83, a dendritic cell lineage associated antigen

Hodgkin’s cells (HC) are considered to be the malignant cells of Hodgkin’s disease (HD), but despite extensive studies, no conclusive evidence has emerged regarding their non-malignant counterpart and the ontogeny of these cells remains controversial. The analysis of a possible dendritic cell (DC) o...

Full description

Saved in:
Bibliographic Details
Published in:Pathology 1997, Vol.29 (3), p.294-299
Main Authors: Sorg, Ursula R., Morse, Timothy M., Nigel Patton, W., Hock, Barry D., Angus, Helen B., Robinson, Bridget A., Colls, Barry M., Hart, Derek N.J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c489t-5d9227ff2e6be18ec1e4cb510c685f97f7bb7ab258eefc4ea892522074a6750b3
cites cdi_FETCH-LOGICAL-c489t-5d9227ff2e6be18ec1e4cb510c685f97f7bb7ab258eefc4ea892522074a6750b3
container_end_page 299
container_issue 3
container_start_page 294
container_title Pathology
container_volume 29
creator Sorg, Ursula R.
Morse, Timothy M.
Nigel Patton, W.
Hock, Barry D.
Angus, Helen B.
Robinson, Bridget A.
Colls, Barry M.
Hart, Derek N.J.
description Hodgkin’s cells (HC) are considered to be the malignant cells of Hodgkin’s disease (HD), but despite extensive studies, no conclusive evidence has emerged regarding their non-malignant counterpart and the ontogeny of these cells remains controversial. The analysis of a possible dendritic cell (DC) origin of HC has been hampered to date by the lack of a DC lineage specific marker. The expression of the two DC-associated antigens CD83 and CMRF-44, the B lymphocyte restricted molecule CD79, and the costimulator molecule CD86, was examined in lymph nodes from 23 HD patients using immunohistological techniques. The majority of HC expressed the CD83 (22/23) and CD86 antigens (20/23), whereas expression of the CMRF-44 antigen was variable (10/23) and usually only a subpopulation of HC stained. In contrast, the CD79 antigen was absent from most HC (17/23). The presence of the CD83 antigen on HC in the absence of the CD79 antigen supports a possible DC lineage odgin for some HC. Regardless of its role in lineage assignment, CD83 may become a useful immunohistological marker for HD as the CD83 antigen was present on most HC.
doi_str_mv 10.1080/00313029700169125
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79239357</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0031302516350280</els_id><sourcerecordid>20401774</sourcerecordid><originalsourceid>FETCH-LOGICAL-c489t-5d9227ff2e6be18ec1e4cb510c685f97f7bb7ab258eefc4ea892522074a6750b3</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EKkvhATgg5YA4NTB24tgWp2opFFGJC5wtxxlvXbLO4skiuPEavB5PgpeNekEqJx_-7x-Nv2HsKYeXHDS8Amh4A8IoAN4ZLuQ9tuJtJ-vGNPw-Wx3yugDyIXtEdAMArdb6hJ0YoTgIvmIfLqdh8yWm3z9_UeVxHKnC77uMRNX6jW7OKlcNmIYc5-j_5tUYE7oNVo5o8tHNOFQuzXGD6TF7ENxI-GR5T9nntxef1pf11cd379fnV7VvtZlrORghVAgCux65Rs-x9b3k4Dstg1FB9b1yvZAaMfgWnTZCCgGqdZ2S0Den7MVx7i5PX_dIs91GOuzmEk57ssqI8n-p_gsKaIEr1RaQH0GfJ6KMwe5y3Lr8w3KwB9P2H9Ol82wZvu-3ONw2FrUlf77kjrwbQ3bJR7rFhOrKpZqCvT5iMYUpb901unG-9i6jvZn2ORWRdy6xtLH4_hYxW_IRk8chZvSzHaZ4R_sPtuypnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20401774</pqid></control><display><type>article</type><title>Hodgkin’s cells express CD83, a dendritic cell lineage associated antigen</title><source>Elsevier</source><creator>Sorg, Ursula R. ; Morse, Timothy M. ; Nigel Patton, W. ; Hock, Barry D. ; Angus, Helen B. ; Robinson, Bridget A. ; Colls, Barry M. ; Hart, Derek N.J.</creator><creatorcontrib>Sorg, Ursula R. ; Morse, Timothy M. ; Nigel Patton, W. ; Hock, Barry D. ; Angus, Helen B. ; Robinson, Bridget A. ; Colls, Barry M. ; Hart, Derek N.J.</creatorcontrib><description>Hodgkin’s cells (HC) are considered to be the malignant cells of Hodgkin’s disease (HD), but despite extensive studies, no conclusive evidence has emerged regarding their non-malignant counterpart and the ontogeny of these cells remains controversial. The analysis of a possible dendritic cell (DC) origin of HC has been hampered to date by the lack of a DC lineage specific marker. The expression of the two DC-associated antigens CD83 and CMRF-44, the B lymphocyte restricted molecule CD79, and the costimulator molecule CD86, was examined in lymph nodes from 23 HD patients using immunohistological techniques. The majority of HC expressed the CD83 (22/23) and CD86 antigens (20/23), whereas expression of the CMRF-44 antigen was variable (10/23) and usually only a subpopulation of HC stained. In contrast, the CD79 antigen was absent from most HC (17/23). The presence of the CD83 antigen on HC in the absence of the CD79 antigen supports a possible DC lineage odgin for some HC. Regardless of its role in lineage assignment, CD83 may become a useful immunohistological marker for HD as the CD83 antigen was present on most HC.</description><identifier>ISSN: 0031-3025</identifier><identifier>EISSN: 1465-3931</identifier><identifier>DOI: 10.1080/00313029700169125</identifier><identifier>PMID: 9271021</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Antibodies, Monoclonal ; Antigens, CD - analysis ; Biological and medical sciences ; CD83 ; CD83 Antigen ; Cell Lineage ; dendritic cells ; Dendritic Cells - immunology ; Hematologic and hematopoietic diseases ; Hodgkin Disease - immunology ; Hodgkin Disease - pathology ; Hodgkins disease ; Humans ; Immunoenzyme Techniques ; Immunoglobulins - analysis ; Immunophenotyping ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences ; Membrane Glycoproteins - analysis ; Tropical medicine</subject><ispartof>Pathology, 1997, Vol.29 (3), p.294-299</ispartof><rights>1997 Royal College of Pathologists of Australasia</rights><rights>1997 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1997</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c489t-5d9227ff2e6be18ec1e4cb510c685f97f7bb7ab258eefc4ea892522074a6750b3</citedby><cites>FETCH-LOGICAL-c489t-5d9227ff2e6be18ec1e4cb510c685f97f7bb7ab258eefc4ea892522074a6750b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2761463$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9271021$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sorg, Ursula R.</creatorcontrib><creatorcontrib>Morse, Timothy M.</creatorcontrib><creatorcontrib>Nigel Patton, W.</creatorcontrib><creatorcontrib>Hock, Barry D.</creatorcontrib><creatorcontrib>Angus, Helen B.</creatorcontrib><creatorcontrib>Robinson, Bridget A.</creatorcontrib><creatorcontrib>Colls, Barry M.</creatorcontrib><creatorcontrib>Hart, Derek N.J.</creatorcontrib><title>Hodgkin’s cells express CD83, a dendritic cell lineage associated antigen</title><title>Pathology</title><addtitle>Pathology</addtitle><description>Hodgkin’s cells (HC) are considered to be the malignant cells of Hodgkin’s disease (HD), but despite extensive studies, no conclusive evidence has emerged regarding their non-malignant counterpart and the ontogeny of these cells remains controversial. The analysis of a possible dendritic cell (DC) origin of HC has been hampered to date by the lack of a DC lineage specific marker. The expression of the two DC-associated antigens CD83 and CMRF-44, the B lymphocyte restricted molecule CD79, and the costimulator molecule CD86, was examined in lymph nodes from 23 HD patients using immunohistological techniques. The majority of HC expressed the CD83 (22/23) and CD86 antigens (20/23), whereas expression of the CMRF-44 antigen was variable (10/23) and usually only a subpopulation of HC stained. In contrast, the CD79 antigen was absent from most HC (17/23). The presence of the CD83 antigen on HC in the absence of the CD79 antigen supports a possible DC lineage odgin for some HC. Regardless of its role in lineage assignment, CD83 may become a useful immunohistological marker for HD as the CD83 antigen was present on most HC.</description><subject>Antibodies, Monoclonal</subject><subject>Antigens, CD - analysis</subject><subject>Biological and medical sciences</subject><subject>CD83</subject><subject>CD83 Antigen</subject><subject>Cell Lineage</subject><subject>dendritic cells</subject><subject>Dendritic Cells - immunology</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hodgkin Disease - immunology</subject><subject>Hodgkin Disease - pathology</subject><subject>Hodgkins disease</subject><subject>Humans</subject><subject>Immunoenzyme Techniques</subject><subject>Immunoglobulins - analysis</subject><subject>Immunophenotyping</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - analysis</subject><subject>Tropical medicine</subject><issn>0031-3025</issn><issn>1465-3931</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkcFu1DAQhi0EKkvhATgg5YA4NTB24tgWp2opFFGJC5wtxxlvXbLO4skiuPEavB5PgpeNekEqJx_-7x-Nv2HsKYeXHDS8Amh4A8IoAN4ZLuQ9tuJtJ-vGNPw-Wx3yugDyIXtEdAMArdb6hJ0YoTgIvmIfLqdh8yWm3z9_UeVxHKnC77uMRNX6jW7OKlcNmIYc5-j_5tUYE7oNVo5o8tHNOFQuzXGD6TF7ENxI-GR5T9nntxef1pf11cd379fnV7VvtZlrORghVAgCux65Rs-x9b3k4Dstg1FB9b1yvZAaMfgWnTZCCgGqdZ2S0Den7MVx7i5PX_dIs91GOuzmEk57ssqI8n-p_gsKaIEr1RaQH0GfJ6KMwe5y3Lr8w3KwB9P2H9Ol82wZvu-3ONw2FrUlf77kjrwbQ3bJR7rFhOrKpZqCvT5iMYUpb901unG-9i6jvZn2ORWRdy6xtLH4_hYxW_IRk8chZvSzHaZ4R_sPtuypnA</recordid><startdate>1997</startdate><enddate>1997</enddate><creator>Sorg, Ursula R.</creator><creator>Morse, Timothy M.</creator><creator>Nigel Patton, W.</creator><creator>Hock, Barry D.</creator><creator>Angus, Helen B.</creator><creator>Robinson, Bridget A.</creator><creator>Colls, Barry M.</creator><creator>Hart, Derek N.J.</creator><general>Elsevier B.V</general><general>Informa UK Ltd</general><general>Taylor and Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>1997</creationdate><title>Hodgkin’s cells express CD83, a dendritic cell lineage associated antigen</title><author>Sorg, Ursula R. ; Morse, Timothy M. ; Nigel Patton, W. ; Hock, Barry D. ; Angus, Helen B. ; Robinson, Bridget A. ; Colls, Barry M. ; Hart, Derek N.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c489t-5d9227ff2e6be18ec1e4cb510c685f97f7bb7ab258eefc4ea892522074a6750b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Antibodies, Monoclonal</topic><topic>Antigens, CD - analysis</topic><topic>Biological and medical sciences</topic><topic>CD83</topic><topic>CD83 Antigen</topic><topic>Cell Lineage</topic><topic>dendritic cells</topic><topic>Dendritic Cells - immunology</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hodgkin Disease - immunology</topic><topic>Hodgkin Disease - pathology</topic><topic>Hodgkins disease</topic><topic>Humans</topic><topic>Immunoenzyme Techniques</topic><topic>Immunoglobulins - analysis</topic><topic>Immunophenotyping</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - analysis</topic><topic>Tropical medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sorg, Ursula R.</creatorcontrib><creatorcontrib>Morse, Timothy M.</creatorcontrib><creatorcontrib>Nigel Patton, W.</creatorcontrib><creatorcontrib>Hock, Barry D.</creatorcontrib><creatorcontrib>Angus, Helen B.</creatorcontrib><creatorcontrib>Robinson, Bridget A.</creatorcontrib><creatorcontrib>Colls, Barry M.</creatorcontrib><creatorcontrib>Hart, Derek N.J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sorg, Ursula R.</au><au>Morse, Timothy M.</au><au>Nigel Patton, W.</au><au>Hock, Barry D.</au><au>Angus, Helen B.</au><au>Robinson, Bridget A.</au><au>Colls, Barry M.</au><au>Hart, Derek N.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hodgkin’s cells express CD83, a dendritic cell lineage associated antigen</atitle><jtitle>Pathology</jtitle><addtitle>Pathology</addtitle><date>1997</date><risdate>1997</risdate><volume>29</volume><issue>3</issue><spage>294</spage><epage>299</epage><pages>294-299</pages><issn>0031-3025</issn><eissn>1465-3931</eissn><abstract>Hodgkin’s cells (HC) are considered to be the malignant cells of Hodgkin’s disease (HD), but despite extensive studies, no conclusive evidence has emerged regarding their non-malignant counterpart and the ontogeny of these cells remains controversial. The analysis of a possible dendritic cell (DC) origin of HC has been hampered to date by the lack of a DC lineage specific marker. The expression of the two DC-associated antigens CD83 and CMRF-44, the B lymphocyte restricted molecule CD79, and the costimulator molecule CD86, was examined in lymph nodes from 23 HD patients using immunohistological techniques. The majority of HC expressed the CD83 (22/23) and CD86 antigens (20/23), whereas expression of the CMRF-44 antigen was variable (10/23) and usually only a subpopulation of HC stained. In contrast, the CD79 antigen was absent from most HC (17/23). The presence of the CD83 antigen on HC in the absence of the CD79 antigen supports a possible DC lineage odgin for some HC. Regardless of its role in lineage assignment, CD83 may become a useful immunohistological marker for HD as the CD83 antigen was present on most HC.</abstract><cop>London</cop><pub>Elsevier B.V</pub><pmid>9271021</pmid><doi>10.1080/00313029700169125</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-3025
ispartof Pathology, 1997, Vol.29 (3), p.294-299
issn 0031-3025
1465-3931
language eng
recordid cdi_proquest_miscellaneous_79239357
source Elsevier
subjects Antibodies, Monoclonal
Antigens, CD - analysis
Biological and medical sciences
CD83
CD83 Antigen
Cell Lineage
dendritic cells
Dendritic Cells - immunology
Hematologic and hematopoietic diseases
Hodgkin Disease - immunology
Hodgkin Disease - pathology
Hodgkins disease
Humans
Immunoenzyme Techniques
Immunoglobulins - analysis
Immunophenotyping
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Membrane Glycoproteins - analysis
Tropical medicine
title Hodgkin’s cells express CD83, a dendritic cell lineage associated antigen
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T02%3A17%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hodgkin%E2%80%99s%20cells%20express%20CD83,%20a%20dendritic%20cell%20lineage%20associated%20antigen&rft.jtitle=Pathology&rft.au=Sorg,%20Ursula%20R.&rft.date=1997&rft.volume=29&rft.issue=3&rft.spage=294&rft.epage=299&rft.pages=294-299&rft.issn=0031-3025&rft.eissn=1465-3931&rft_id=info:doi/10.1080/00313029700169125&rft_dat=%3Cproquest_cross%3E20401774%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c489t-5d9227ff2e6be18ec1e4cb510c685f97f7bb7ab258eefc4ea892522074a6750b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20401774&rft_id=info:pmid/9271021&rfr_iscdi=true